LMNA and familial dilated cardiomyopathy: The prognosis of LMNA patients is worse compared to other familial DCMs: in fact, by the age of 45 years, carriers of LMNA mutations presented cardiovascular death, HTx, or at least one major event (hospitalization for HF deterioration, VA or thromboembolic event) in 69% vs. 25% in familial DCM patients without LMNA mutations [4].